Abstract
To diagnose Alzheimer’s disease (AD) early, tests sensitive to neuropathology and insensitive to normal ageing are of greatest benefit. We used several neuropsychological tests to identify those best suited to distinguishing Mild Cognitive Impairment (MCI) and early AD from normal ageing. Impairments in long-term memory were found in older adults and these were even greater in MCI and AD. Older adults outperformed young controls on category fluency and produced later acquired and less familiar words. Older adults also outperformed both patient groups on this task producing more words which were significantly later acquired, less familiar and less typical. Decline in long-term memory appears nonspecific and in the early stage of AD cannot help the differentiation between normal and pathological brain ageing. Normal ageing has no negative effects on verbal fluency, and impairment on this task signals not only established AD, but also its prodromal MCI stage.
Keywords: Age of acquisition, Alzheimer's disease, episodic memory, mild cognitive impairment, semantic memory, verbal fluency.
Current Alzheimer Research
Title:Differentiating Normal from Pathological Brain Ageing Using Standard Neuropsychological Tests
Volume: 11 Issue: 8
Author(s): Sarah J. Wakefield, William J. McGeown, Michael F. Shanks and Annalena Venneri
Affiliation:
Keywords: Age of acquisition, Alzheimer's disease, episodic memory, mild cognitive impairment, semantic memory, verbal fluency.
Abstract: To diagnose Alzheimer’s disease (AD) early, tests sensitive to neuropathology and insensitive to normal ageing are of greatest benefit. We used several neuropsychological tests to identify those best suited to distinguishing Mild Cognitive Impairment (MCI) and early AD from normal ageing. Impairments in long-term memory were found in older adults and these were even greater in MCI and AD. Older adults outperformed young controls on category fluency and produced later acquired and less familiar words. Older adults also outperformed both patient groups on this task producing more words which were significantly later acquired, less familiar and less typical. Decline in long-term memory appears nonspecific and in the early stage of AD cannot help the differentiation between normal and pathological brain ageing. Normal ageing has no negative effects on verbal fluency, and impairment on this task signals not only established AD, but also its prodromal MCI stage.
Export Options
About this article
Cite this article as:
Wakefield J. Sarah, McGeown J. William, Shanks F. Michael and Venneri Annalena, Differentiating Normal from Pathological Brain Ageing Using Standard Neuropsychological Tests, Current Alzheimer Research 2014; 11 (8) . https://dx.doi.org/10.2174/156720501108140910121631
DOI https://dx.doi.org/10.2174/156720501108140910121631 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antibiotics with Antiviral and Anti-Inflammatory Potential Against
Covid-19: A Review
Current Reviews in Clinical and Experimental Pharmacology Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions
Current Gene Therapy Meet Our Editorial Board Member
Current Medicinal Chemistry AAV-Mediated Gene Transfer for Treatment of Hemophilia
Current Gene Therapy Can the Use of HIV-1 Derived Gene Transfer Vectors for Clinical Application be Justified?
Current Gene Therapy Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model
Current Pharmaceutical Design Can Targeted Therapy be Successful without Metronomic Scheduling ?
Current Topics in Medicinal Chemistry Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Meet the Editorial Board
Combinatorial Chemistry & High Throughput Screening Convection Enhanced Delivery of Macromolecules for Brain Tumors
Current Drug Discovery Technologies Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy Before and After Preeclampsia: What Biomarkers are there?
Current Women`s Health Reviews Tailored Multi-Target Agents. Applications and Design Considerations
Current Pharmaceutical Design Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends
Current Topics in Medicinal Chemistry The Relevance of Supplemental Vitamin D in Malignancies
Anti-Cancer Agents in Medicinal Chemistry Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Targeting Cancer Cells by an Oxidant-Based Therapy
Current Molecular Pharmacology Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design